Prelude Therapeutics Stock (NASDAQ: PRLD)
|Day Range6.22 - 6.64||52 Wk Range3.87 - 13.4||Open / Close6.48 / -||Float / Outstanding6.8M / 47.8M|
|Vol / Avg.20.3K / 95.3K||Mkt Cap317.6M||P/E-||50d Avg. Price7.06|
|Div / Yield-||Payout Ratio-||Total Float6.8M||EPS-0.58|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.
The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by Morgan Stanley on Friday, September 9, 2022. The analyst firm set a price target for 11.00 expecting PRLD to rise to within 12 months (a possible 65.66% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $6.64 last updated Today at September 28, 2022, 3:32 PM UTC.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.